OREANDA-NEWS. Currently, the global infusion pumps market is crowded with many active players introducing a wide variety of specialties across the globe. Key players operating in the global infusion pumps market are focusing on introducing new varieties of insulin pumps, ambulatory pumps, large volume pumps, implantable infusion pumps, disposable pumps, and enteral feeding pumps. Technology advancements have helped companies to focus more on manufacturing disposable infusion pumps, which are in demand among hospitals, clinics, and healthcare centers in many areas. 
Top companies including CareFusion Corporation, Baxter International, Inc., B. Braun Melsungen AG, and Hospira, Inc. are taking efforts to enhance their already existing infusion pumps. Transparency Market Research (TMR), in its new report, states that the global market for infusion pumps is expected to witness significant growth owing to the rising aging population. As per the report, the global market recorded US$5.4 bn in 2012 and is predicted to reach US$7.7 bn by 2019, progressing at a 5.30% CAGR. 
TMR experts answer the following questions related to the global infusion pumps market, that the companies operating in this market might want to ask:
Q. Will increasing patient base benefit the global market for infusion pumps?
Yes, the increasing patient base is one of the primary factors expected to drive the global market for infusion pumps. Among all health problems, the number of people diagnosed with diabetes is increasing considerably. An uptick in diabetic people is expected to be responsible for the steady expansion of the global infusion pumps market. Apart from this, the market is also expected to be benefited from rising aging population. Technological advancements in the medical devices are predicted to further contribute towards the growth of the global market. 
Q. What are the factors expected to restrict the growth of the global infusion pumps market?
Many healthcare clinics and hospitals in various locations reported problems in infusion pumps, leading to product recalls. The patient protection and affordable care act also impose many restrictions on the use of medical devices considering the device problems. Stringent government rules and regulations restrict the entry of new companies in the global infusion pumps market. All these factors are expected to restrict the growth of the global market for infusion pumps in the near future. 
Q. Will new product launches and awareness programs benefit the global demand for new infusion pumps?
Yes, emerging nations are offering many opportunities to manufacturers to introduce their new products in the global market. The availability of enough medical infrastructure is also predicted to benefit manufacturers to launch new products. Many companies are involved in infusion pumps analysis services to reveal key practices that contribute to the smart pump workarounds. 
For instance, B. Braun, a leading company was recently in the news for launching its infusion safety analysis service that was designed to assure meaningful use of infusion pumps. The infusion pumps safety analysis service helped reveal top infusions pumps. 
The global market for infusion pumps is moving towards smart technology. Key companies are engaged in manufacturing smart infusion pumps with high capacity to avoid errors related to dosing.